Series A funding

Fathom Therapeutics Raises $47M to Advance AI Drug Design

NEW YORK, April 27, 2026 Fathom Therapeutics has announced the successful completion of an oversubscribed $47 million Series A...

By cGxPwire Editor
April 28, 2026

.VC

Vivatides Therapeutics Raises $54M to Expand RNA Therapies

Boston, Massachusetts | April 13, 2026 Vivatides Therapeutics has announced the successful completion of a $54 million oversubscribed Series...

By cGxPwire Editor
April 14, 2026

Bio-Pharma

Gilgamesh Pharma Raises $60M for Neuro Therapies

NEW YORK, USA | March 24, 2026 Gilgamesh Pharma, a clinical-stage neuroscience company focused on next-generation neuropsychiatric therapeutics, has...

By cGxPwire Editor
March 25, 2026

.VC Bio-Pharma

R1 Therapeutics Launches with $77.5M Series A to Advance CKD Treatment

Redwood City, CA – March 17, 2026 – R1 Therapeutics has officially emerged from stealth mode, announcing an oversubscribed...

By cGxPwire Editor
March 17, 2026

MedTech

Brain-Computer Interface Trial Signals New Era in Stroke Rehab

NEW ORLEANS, February 3, 2026 — Kandu, Inc., a healthcare technology company specializing in brain–computer interface (BCI)–enabled stroke recovery...